Skip to content

Opening book details…

About this Immunology and Microbiology article

Thrombin-activatable fibrinolysis inhibitor (TAFI) is enhanced in major trauma patients without infectious complications by Relja, B.; Lustenberger, T.; Puttkammer, B.; Jakob, H.; Morser, J.; Gabazza, E.C.; Takei, Y.; Marzi, I. is a Immunology and Microbiology article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Immunology and Microbiology.

Author
Relja, B.; Lustenberger, T.; Puttkammer, B.; Jakob, H.; Morser, J.; Gabazza, E.C.; Takei, Y.; Marzi, I.
Publisher
Elsevier Science; Elsevier ; Elsevier BV (ISSN 0171-2985)
Published
2013
Language
EN
Field
Immunology and Microbiology (Life Sciences)

More by Relja, B.; Lustenberger, T.; Puttkammer, B.; Jakob, H.; Morser, J.; Gabazza, E.C.; Takei, Y.; Marzi, I.

Browse all works by Relja, B.; Lustenberger, T.; Puttkammer, B.; Jakob, H.; Morser, J.; Gabazza, E.C.; Takei, Y.; Marzi, I.